Skip to main content
. 2023 Jul 21;13:1222716. doi: 10.3389/fonc.2023.1222716

Figure 2.

Figure 2

Summary of the number of physical mutated genes in tube issue, mutation type, and periodic ctDNA testing in 90 evaluable patients with NSCLC. (A) Number of physical mutations in tube issue. (B) Candidate driver genes that are frequently mutated in tube issue. (C) Patient's mutation type, and MRD status.